Alembic Pharmaceuticals

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue1,7171,9171,8921,8732,165
Expenses1,5271,6951,6861,7311,943
EBITDA287.85322.60309.00253.42346.79
Operating Profit213.63247.95184.81141.18249.47
Profit Before Tax190.11223.72161.50118.62221.86
Net Profit153.63183.71131.95201.53172.36
Financial Ratios
Operating Profit Margin16.80%16.96%14.12%12.44%16.15%
Net Profit Margin9.02%9.67%8.93%11.96%8.05%
Earning Per Share (Diluted)7.859.406.7610.318.80
Dividends Per Share0.000.000.000.000.00